Readers and medical professionals discuss the Trump administration halting communication and travel at HHS. Regarding the Jan ...

The pause has potentially left the public in the dark about updates to scientific research and public health issues like flu outbreaks ...

The IRA’s price controls discourage post-marketing research. The potential benefits from expanding access to the drug to ...

The past three administrations have tried to limit gain-of-function research. The second Trump administration might be the ...

Former NFL quarterback Tom Brady's ex-wife Gisele Bündchen persistently urged him to retire after his Super Bowl LI victory ...

When European legal giant CMS announced it was developing its Noxtua AI large language model a year ago, the AI market looked ...

Tymal Mills reflects on his journey as a T20 globe-trotter, recounting experiences in various leagues, including IPL, ILT20, ...

Pete Hegseth, nominee for defense secretary, paid $50,000 to settle a sexual assault accusation from 2017. He maintains his ...

Other HHS staffers were helping support arrangements ... more than two decades before becoming California’s top lawyer in 2017 and then the nation’s health secretary in 2021, is a veteran ...

The CMS listed Ozempic, Rybelsus and Wegovy ... years old — Ozempic just meets this requirement, given its December 2017 approval. A drug also must not have any generic or biosimilars ...

The Senate is set to churn through more of President Trump’s Cabinet nominees this week, with a handful of his controversial picks set to field questions during their confirmation hearings. Tulsi ...